EQUISUL-SDT® (Sulfadiazine/Trimethoprim)
EQUISUL-SDT® is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus equi subsp. zooepidemicus. EQUISUL-SDT® is produced using Aurora Pharmaceutical’s patented drug product formulation. The product demonstrated 20% increased bioavailability over an existing paste product in a pharmacokinetic crossover study.
Product Features
- Safety was demonstrated in a controlled study in horses at 1X, 3X and 5X the recommended dose for 30 days
- Low incidence of side effects in controlled safety studies
- Easy-to-use, apple-f lavored liquid formulation
- Significantly higher bioavailability on a mg-to-mg basis compared to an approved paste product, based on a pharmacokinetic crossover study
Availability
*Includes draw-off cap
135 mL Bottle — Reorder No: 28000
*280 mL Bottle — Reorder No: 28003
*560 mL Bottle — Reorder No: 28002
900 mL Bottle — Reorder No: 28001
Clicking a link on this page will open a PDF file in a new window.
